Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129

Benzer Materyaller

• Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
  Yazar:: Lai, Shih-Wei, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
  Yazar:: Morbach, Stephan, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Response to Yang and Chan. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
  Yazar:: Suissa, Samy, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757
  Yazar:: Baldi, James C., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Response to Bodmer et al. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
  Yazar:: Suissa, Samy, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)